Compulsory licensing

Patent challenge

Print edition : November 15, 2013

The generic cancer drug sorafenib tosylate drugs manufactured by Natco. Bayer Corporation's May 2013 petition challenges an order of the Intellectual Property Appellate Board, issued in March 2013, upholding the compulsory licence granted to Balco. Photo: Mahesh Kumar A. /AP

Pharma giant Bayer’s petition in the Bombay High Court against the issue of compulsory licence to Natco is one in a series of patent infringement suits filed against generic drug companies.
    This article is closed for comments.
    Please Email the Editor
    ×